Poorer prognosis in patients. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Cell Line, Tumor Lymph Nodes Bile Ducts, Intrahepatic Neoplastic Cells, Circulating Tumor Cells, Cultured Lymphocytes, Tumor-Infiltrating

Organisms1

Diseases78

Breast Neoplasms Lymphatic Metastasis Adenocarcinoma Disease Progression Neoplasm Invasiveness Neoplasm Recurrence, Local Lung Neoplasms Carcinoma, Squamous Cell Liver Neoplasms Neoplasm Metastasis Stomach Neoplasms Carcinoma Recurrence Carcinoma, Hepatocellular Brain Neoplasms Colorectal Neoplasms Esophageal Neoplasms Pancreatic Neoplasms Melanoma Acute Disease Heart Failure Ovarian Neoplasms Adenocarcinoma, Mucinous Neoplasms Carcinoma, Non-Small-Cell Lung Myocardial Infarction Skin Neoplasms Kidney Neoplasms Cholangiocarcinoma Bile Duct Neoplasms Carcinoma, Ductal, Breast Chromosome Aberrations Glioblastoma Neuroblastoma Bone Neoplasms Lymphoma, Large B-Cell, Diffuse Carcinoma, Renal Cell Gallbladder Neoplasms Sarcoma Glioma Leukemia, Myeloid, Acute Mouth Neoplasms Head and Neck Neoplasms Carcinoma, Pancreatic Ductal Neovascularization, Pathologic Precursor Cell Lymphoblastic Leukemia-Lymphoma Chronic Disease Astrocytoma Carcinoma, Papillary Syndrome Osteosarcoma Colonic Neoplasms Thyroid Neoplasms Prostatic Neoplasms Lymphoma, Non-Hodgkin Remission, Spontaneous Rectal Neoplasms Carcinoma, Adenosquamous Neoplastic Cells, Circulating Neoplasms, Glandular and Epithelial Neoplasms, Germ Cell and Embryonal Endometrial Neoplasms Urinary Bladder Neoplasms Translocation, Genetic Lymphoma, T-Cell Leukemia, Lymphocytic, Chronic, B-Cell Nasopharyngeal Neoplasms Coma Pleural Neoplasms Lymphoma Gastrointestinal Neoplasms Lymphoma, B-Cell Pregnancy Complications, Neoplastic Cell Transformation, Neoplastic Uterine Cervical Neoplasms Ventricular Dysfunction, Left Carcinoma, Signet Ring Cell Hodgkin Disease

Chemicals and Drugs27

Tumor Markers, Biological Biological Markers Neoplasm Proteins Receptor, erbB-2 Antineoplastic Agents Ki-67 Antigen Receptors, Estrogen Tumor Suppressor Protein p53 DNA, Neoplasm RNA, Messenger Receptors, Progesterone Vincristine Antigens, Neoplasm Cyclophosphamide alpha-Fetoproteins Doxorubicin MicroRNAs RNA, Neoplasm Tumor Suppressor Proteins Prednisone Cisplatin Proto-Oncogene Proteins Receptor, Epidermal Growth Factor Nuclear Proteins Carcinoembryonic Antigen RNA, Small Interfering Vascular Endothelial Growth Factor A

Analytical, Diagnostic and Therapeutic Techniques and Equipment68

Prognosis Survival Analysis Survival Rate Neoplasm Staging Retrospective Studies Follow-Up Studies Kaplan-Meier Estimate Treatment Outcome Immunohistochemistry Disease-Free Survival Multivariate Analysis Proportional Hazards Models Predictive Value of Tests Risk Factors Prospective Studies Cohort Studies Combined Modality Therapy Tissue Array Analysis Gene Expression Profiling Neoplasm Grading Antineoplastic Combined Chemotherapy Protocols Immunoenzyme Techniques Tomography, X-Ray Computed Risk Assessment Severity of Illness Index Reverse Transcriptase Polymerase Chain Reaction Fatal Outcome Chi-Square Distribution Oligonucleotide Array Sequence Analysis Biopsy Chemotherapy, Adjuvant Sensitivity and Specificity Incidence Case-Control Studies ROC Curve In Situ Hybridization, Fluorescence Magnetic Resonance Imaging Registries Remission Induction Polymerase Chain Reaction Reproducibility of Results Mitotic Index Gastrectomy Electrocardiography Regression Analysis Real-Time Polymerase Chain Reaction Blotting, Western Tumor Burden Karyotyping Palliative Care Lymph Node Excision Radiotherapy, Adjuvant Analysis of Variance Actuarial Analysis Statistics, Nonparametric Risk Clinical Trials as Topic Neoadjuvant Therapy DNA Mutational Analysis Life Tables Cause of Death Hepatectomy Early Diagnosis Logistic Models Hospital Mortality Echocardiography Hospitalization Stroke Volume

Psychiatry and Psychology1

Truth Disclosure

Phenomena and Processes24

Gene Expression Regulation, Neoplastic Time Factors Chi-Square Distribution Mutation Sensitivity and Specificity Cell Proliferation Chromosome Aberrations DNA Methylation Ploidies Gene Amplification Apoptosis Drug Resistance, Neoplasm Phenotype Genes, p53 Signal Transduction Up-Regulation Risk Remission, Spontaneous Genotype Translocation, Genetic Gene Expression Genes, erbB-2 Stroke Volume Pregnancy

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Truth Disclosure Survival

Information Science7

Survival Rate Fatal Outcome Incidence Registries Life Tables Cause of Death Hospital Mortality

Named Groups1

Infant, Newborn

Health Care38

Survival Analysis Survival Rate Retrospective Studies Follow-Up Studies Kaplan-Meier Estimate Treatment Outcome Disease-Free Survival Multivariate Analysis Proportional Hazards Models Predictive Value of Tests Risk Factors Prospective Studies Cohort Studies Age Factors Risk Assessment Severity of Illness Index Fatal Outcome Chi-Square Distribution Sensitivity and Specificity Incidence Case-Control Studies ROC Curve Registries Reproducibility of Results Sex Factors Regression Analysis Palliative Care Analysis of Variance Actuarial Analysis Statistics, Nonparametric Risk Clinical Trials as Topic Life Tables Cause of Death Logistic Models Hospital Mortality Hospitalization Age of Onset

Geographicals2

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Prognosis Survival Analysis Tumor Markers, Biological Survival Rate Neoplasm Staging Retrospective Studies Follow-Up Studies Kaplan-Meier Estimate Treatment Outcome Immunohistochemistry Breast Neoplasms Disease-Free Survival Multivariate Analysis Lymphatic Metastasis Proportional Hazards Models Predictive Value of Tests Gene Expression Regulation, Neoplastic Time Factors Adenocarcinoma Disease Progression Neoplasm Invasiveness Risk Factors Prospective Studies Neoplasm Recurrence, Local Lung Neoplasms Carcinoma, Squamous Cell Cell Line, Tumor Liver Neoplasms Neoplasm Metastasis Stomach Neoplasms Cohort Studies Combined Modality Therapy Tissue Array Analysis Carcinoma Gene Expression Profiling Recurrence Carcinoma, Hepatocellular Neoplasm Grading Brain Neoplasms Age Factors Colorectal Neoplasms Antineoplastic Combined Chemotherapy Protocols Biological Markers Neoplasm Proteins Esophageal Neoplasms Receptor, erbB-2 Immunoenzyme Techniques Tomography, X-Ray Computed Risk Assessment Severity of Illness Index Pancreatic Neoplasms Antineoplastic Agents Reverse Transcriptase Polymerase Chain Reaction Melanoma Acute Disease Ki-67 Antigen Heart Failure Ovarian Neoplasms Receptors, Estrogen Adenocarcinoma, Mucinous Neoplasms Carcinoma, Non-Small-Cell Lung Tumor Suppressor Protein p53 Myocardial Infarction DNA, Neoplasm Skin Neoplasms Fatal Outcome Kidney Neoplasms Chi-Square Distribution Oligonucleotide Array Sequence Analysis Mutation Biopsy Chemotherapy, Adjuvant RNA, Messenger Japan Sensitivity and Specificity Receptors, Progesterone Incidence Cell Proliferation Case-Control Studies Lymph Nodes Cholangiocarcinoma Bile Duct Neoplasms Carcinoma, Ductal, Breast Chromosome Aberrations ROC Curve In Situ Hybridization, Fluorescence Glioblastoma Neuroblastoma Bone Neoplasms Lymphoma, Large B-Cell, Diffuse Magnetic Resonance Imaging Carcinoma, Renal Cell Gallbladder Neoplasms Registries DNA Methylation Remission Induction Sarcoma Infant, Newborn Polymerase Chain Reaction

No FAQ available that match "poorer prognosis in patients"